Predictors of outcome in early-onset psychosis: A systematic review

npj Schizophrenia

Volumn 1, Issue 1, 2015, Pages

  Díaz Caneja, Covadonga M ^a   Pina Camacho, Laura ^a,b   Rodríguez Quiroga, Alberto ^a   Fraguas, David ^a   Parellada, Mara ^a   Arango, Celso ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN SIZE; CORTICAL THICKNESS (BRAIN); DEPRESSION; DEVELOPMENTAL DELAY; DISEASE DURATION; DISEASE SEVERITY; EARLY ONSET PSYCHOSIS; GRAY MATTER; HUMAN; INTELLIGENCE QUOTIENT; ONSET AGE; PRIORITY JOURNAL; PSYCHOSIS; QUALITY OF LIFE; REMISSION; REVIEW; SCHIZOPHRENIA; SUICIDE ATTEMPT; SYSTEMATIC REVIEW;

EID: 84956578670     PISSN: None     EISSN: 2334265X     Source Type: Journal    
DOI: 10.1038/npjschz.2014.5     Document Type: Review

References (118)

1. Gore FM, Bloem PJ, Patton GC, Ferguson J, Joseph V, Coffey C et al. Global burden of disease in young people aged 10-24 years: a systematic analysis. Lancet 2011; 377: 2093-2102.
2. Madhusoodanan S. Preventive psychiatry: we are getting closer to fulfilling the promise of reducing mental illness. Ann Clin Psychiatry 2010; 22: 217-218.
3. McGorry PD. Risk syndromes, clinical staging and DSM V: new diagnostic infrastructure for early intervention in psychiatry. Schizophr Res 2010; 120: 49-53.
4. Patton GC, Coffey C, Romaniuk H, Mackinnon A, Carlin JB, Degenhardt L et al. The prognosis of common mental disorders in adolescents: a 14-year prospective cohort study. Lancet 2014; 383: 1404-1411.
5. Hazell P. Does the treatment of mental disorders in childhood lead to a healthier adulthood? Curr Opin Psychiatry 2007; 20: 315-318.
6. McFarlane WR, Levin B, Travis L, Lucas FL, Lynch S, Verdi M et al. Clinical and functional outcomes after 2 years in the early detection and intervention for the prevention of psychosis multisite effectiveness trial. Schizophr Bull 2015; 41: 30-43.
7. Francey SM, Nelson B, Thompson A, Parker AG, Kerr M, Macneil C et al. Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention. Schizophr Res 2010; 119: 1-10.
8. de Girolamo G, Dagani J, Purcell R, Cocchi A, McGorry PD. Age of onset of mental disorders and use of mental health services: needs, opportunities and obstacles. Epidemiol Psychiatr Sci 2012; 21: 47-57.
9. Beardslee WR, Brent DA, Weersing VR, Clarke GN, Porta G, Hollon SD et al. Prevention of depression in at-risk adolescents: longer-Term effects. JAMA Psychiatry 2013; 70: 1161-1170.
10. Schimmelmann BG, Conus P, Cotton S, McGorry PD, Lambert M. Pre-Treatment, baseline, and outcome differences between early-onset and adult-onset psychosis in an epidemiological cohort of 636 first-episode patients. Schizophr Res 2007; 95: 1-8.
11. Amminger GP, Henry LP, Harrigan SM, Harris MG, Alvarez-Jimenez M, Herrman H et al. Outcome in early-onset schizophrenia revisited: findings from the Early Psychosis Prevention and Intervention Centre long-Term follow-up study. Schizophr Res 2011; 131: 112-119.
12. Hafner H, Nowotny B. Epidemiology of early-onset schizophrenia. Eur Arch Psychiatry Clin Neurosci 1995; 245: 80-92.
13. Clemmensen L, Vernal DL, Steinhausen HC. A systematic review of the long-Term outcome of early onset schizophrenia. BMC Psychiatry 2012; 12: 150.
14. Zipursky RB, Reilly TJ, Murray RM. The myth of schizophrenia as a progressive brain disease. Schizophr Bull 2013; 39: 1363-1372.
15. Wunderink L, Nieboer RM, Wiersma D, Sytema S, Nienhuis FJ. Recovery in remitted first-episode psychosis at 7 years of follow-up of an early dose reduction/discontinuation or maintenance treatment strategy: long-Term followup of a 2-year randomized clinical trial. JAMA Psychiatry 2013; 70: 913-920.
16. Menezes NM, Milovan E. First-episode psychosis: a comparative review of diagnostic evolution and predictive variables in adolescents versus adults. Can J Psychiatry 2000; 45: 710-716.
17. Remschmidt H, Theisen F. Early-onset schizophrenia. Neuropsychobiology 2012; 66: 63-69.
18. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-Analyses: the PRISMA statement. BMJ 2009; 339: b2535.
19. Rutter M. Childhood schizophrenia reconsidered. J Autism Child Schizophr 1972; 2: 315-337.
20. Gillberg IC, Hellgren L, Gillberg C. Psychotic disorders diagnosed in adolescence. Outcome at age 30 years. J Child Psychol Psychiatry 1993; 34: 1173-1185.
21. Remberk B, Bazynska AK, Krempa-Kowalewska A, Rybakowski F. Adolescent insanity revisited: course and outcome in early-onset schizophrenia spectrum psychoses in an 8-year follow-up study. Compr Psychiatry 2014; 55: 1174-1181.
22. Paillere-Martinot ML, Aubin F, Martinot JL, Colin B. A prognostic study of clinical dimensions in adolescent-onset psychoses. Schizophr Bull 2000; 26: 789-799.
23. Bachman P, Niendam TA, Jalbrzikowski M, Park CY, Daley M, Cannon TD et al. Processing speed and neurodevelopment in adolescent-onset psychosis: cognitive slowing predicts social function. J Abnorm Child Psychol 2012; 40: 645-654.
24. Valevski A, Ratzoni G, Sever J, Apter A, Zalsman G, Shiloh R et al. Stability of diagnosis: a 20-year retrospective cohort study of Israeli psychiatric adolescent inpatients. J Adolesc 2001; 24: 625-633.
25. Pencer A, Addington J, Addington D. Outcome of a first episode of psychosis in adolescence: a 2-year follow-up. Psychiatry Res 2005; 133: 35-43.
26. Hassan GA, Taha GR. Long term functioning in early onset psychosis: two years prospective follow-up study. Behav Brain Funct 2011; 7: 28.
27. Maziade M, Gingras N, Rodrigue C, Bouchard S, Cardinal A, Gauthier B et al. Longterm stability of diagnosis and symptom dimensions in a systematic sample of patients with onset of schizophrenia in childhood and early adolescence. I: nosology, sex and age of onset. Br J Psychiatry 1996; 169: 361-370.
28. Meng H, Schimmelmann BG, Mohler B, Lambert M, Branik E, Koch E et al. Pretreatment social functioning predicts 1-year outcome in early onset psychosis. Acta Psychiatr Scand 2006; 114: 249-256.
29. Fraguas D, Merchan-Naranjo J, Del Rey-Mejias A, Castro-Fornieles J, Gonzalez-Pinto A, Rapado-Castro M et al. A longitudinal study on the relationship between duration of untreated psychosis and executive function in early-onset first-episode psychosis. Schizophr Res 2014; 158: 126-133.
30. Lay B, Blanz B, Hartmann M, Schmidt MH. The psychosocial outcome of adolescent-onset schizophrenia: a 12-year followup. Schizophr Bull 2000; 26: 801-816.
31. Krausz M, Muller-Thomsen T. Schizophrenia with onset in adolescence: an 11-year followup. Schizophr Bull 1993; 19: 831-841.
32. Reichert A, Kreiker S, Mehler-Wex C, Warnke A. The psychopathological and psychosocial outcome of early-onset schizophrenia: preliminary data of a 13-year follow-up. Child Adolesc Psychiatry Ment Health 2008; 2: 6.
33. Fraguas D, de Castro MJ, Medina O, Parellada M, Moreno D, Graell M et al. Does diagnostic classification of early-onset psychosis change over follow-up? Child Psychiatry Hum Dev 2008; 39: 137-145.
34. Aarkrog T. Psychotic adolescents 20-25 years later. Nord J Psychiatry 1999; 53 (Suppl 42(i-vIII)): 1-38.
35. Pina-Camacho L, Garcia-Prieto J, Parellada M, Castro-Fornieles J, Gonzalez-Pinto AM, Bombin I et al. Predictors of schizophrenia spectrum disorders in early-onset first episodes of psychosis: a support vector machine model. Eur Child Adolesc Psychiatry 2014 Aug 11. [Epub ahead of print]. doi:10.1007/s00787-014-0593-0.
36. Hollis C. Developmental precursors of child-And adolescent-onset schizophrenia and affective psychoses: diagnostic specificity and continuity with symptom dimensions. Br J Psychiatry 2003; 182: 37-44.
37. Strauss GP, Allen DN, Miski P, Buchanan RW, Kirkpatrick B, Carpenter WT Jr. Differential patterns of premorbid social and academic deterioration in deficit and nondeficit schizophrenia. Schizophr Res 2012; 135: 134-138.
38. Owen MJ, O'Donovan MC, Thapar A, Craddock N. Neurodevelopmental hypothesis of schizophrenia. Br J Psychiatry 2011; 198: 173-175.
39. Hollis C. Adult outcomes of child-And adolescent-onset schizophrenia: diagnostic stability and predictive validity. Am J Psychiatry 2000; 157: 1652-1659.
40. Lang FU, Kosters M, Lang S, Becker T, Jager M. Psychopathological long-Term outcome of schizophrenia -A review. Acta Psychiatr Scand 2013; 127: 173-182.
41. Chang WC, Tang JY, Hui CL, Wong GH, Chan SK, Lee EH et al. The relationship of early premorbid adjustment with negative symptoms and cognitive functions in first-episode schizophrenia: a prospective three-year follow-up study. Psychiatry Res 2013; 209: 353-360.
42. McGlashan TH. The prediction of outcome in chronic schizophrenia. IV. The Chestnut Lodge follow-up study. Arch Gen Psychiatry 1986; 43: 167-176.
43. Ballageer T, Malla A, Manchanda R, Takhar J, Haricharan R. Is adolescent-onset first-episode psychosis different from adult onset? J Am Acad Child Adolesc Psychiatry 2005; 44: 782-789.
44. Joa I, Johannessen JO, Langeveld J, Friis S, Melle I, Opjordsmoen S et al. Baseline profiles of adolescent vs. adult-onset first-episode psychosis in an early detection program. Acta Psychiatr Scand 2009; 119: 494-500.
45. Vourdas A, Pipe R, Corrigall R, Frangou S. Increased developmental deviance and premorbid dysfunction in early onset schizophrenia. Schizophr Res 2003; 62: 13-22.
46. Fraguas D, Llorente C, Rapado-Castro M, Parellada M, Moreno D, Ruiz-Sancho A et al. Attitude toward antipsychotic medication as a predictor of antipsychotic treatment discontinuation in first-episode early-onset psychosis. Rev Psiquiatr Salud Ment 2008; 1: 10-17.
47. McClellan JM, Werry JS, Ham M. A follow-up study of early onset psychosis: comparison between outcome diagnoses of schizophrenia, mood disorders, and personality disorders. J Autism Dev Disord 1993; 23: 243-262.
48. Lay B, Schmidt MH, Blanz B. Course of adolescent psychotic disorder with schizoaffective episodes. Eur Child Adolesc Psychiatry 1997; 6: 32-41.
49. Bombin I, Mayoral M, Castro-Fornieles J, Gonzalez-Pinto A, de la Serna E, Rapado-Castro M et al. Neuropsychological evidence for abnormal neurodevelopment associated with early-onset psychoses. Psychol Med 2013; 43: 757-768.
50. Fraguas D, Del Rey-Mejias A, Moreno C, Castro-Fornieles J, Graell M, Otero S et al. Duration of untreated psychosis predicts functional and clinical outcome in children and adolescents with first-episode psychosis: a 2-year longitudinal study. Schizophr Res 2014; 152: 130-138.
51. Jepsen JR, Fagerlund B, Pagsberg AK, Christensen AM, Hilker RW, Nordentoft M et al. Course of intelligence deficits in early onset, first episode schizophrenia: a controlled, 5-year longitudinal study. Eur Child Adolesc Psychiatry 2010; 19: 341-351.
52. Arango C, Fraguas D, Parellada M. Differential neurodevelopmental trajectories in patients with early-onset bipolar and schizophrenia disorders. Schizophr Bull 2014; 40(Suppl 2): S138-S146.
53. Janssen J, Aleman-Gomez Y, Schnack H, Balaban E, Pina-Camacho L, Alfaro-Almagro F et al. Cortical morphology of adolescents with bipolar disorder and with schizophrenia. Schizophr Res 2014; 158: 91-99.
54. Demjaha A, MacCabe JH, Murray RM. How genes and environmental factors determine the different neurodevelopmental trajectories of schizophrenia and bipolar disorder. Schizophr Bull 2012; 38: 209-214.
55. McClellan J, McCurry C, Snell J, DuBose A. Early-onset psychotic disorders: course and outcome over a 2-year period. J Am Acad Child Adolesc Psychiatry 1999; 38: 1380-1388.
56. Werry JS, McClellan JM. Predicting outcome in child and adolescent (early onset) schizophrenia and bipolar disorder. J Am Acad Child Adolesc Psychiatry 1992; 31: 147-150.
57. Castro-Fornieles J, Baeza I, de la Serna E, Gonzalez-Pinto A, Parellada M, Graell M et al. Two-year diagnostic stability in early-onset first-episode psychosis. J Child Psychol Psychiatry 2011; 52: 1089-1098.
58. Juola P, Miettunen J, Veijola J, Isohanni M, Jaaskelainen E. Predictors of short-And long-Term clinical outcome in schizophrenic psychosis-The Northern Finland 1966 Birth Cohort study. Eur Psychiatry 2013; 28: 263-268.
59. Marshall M, Lewis S, Lockwood A, Drake R, Jones P, Croudace T. Association between duration of untreated psychosis and outcome in cohorts of firstepisode patients: a systematic review. Arch Gen Psychiatry 2005; 62: 975-983.
60. Perkins DO, Gu H, Boteva K, Lieberman JA. Relationship between duration of untreated psychosis and outcome in first-episode schizophrenia: a critical review and meta-Analysis. Am J Psychiatry 2005; 162: 1785-1804.
61. Penttila M, Jaaskelainen E, Hirvonen N, Isohanni M, Miettunen J. Duration of untreated psychosis as predictor of long-Term outcome in schizophrenia: systematic review and meta-Analysis. Br J Psychiatry 2014; 205: 88-94.
62. Ropcke B, Eggers C. Early-onset schizophrenia: a 15-year follow-up. Eur Child Adolesc Psychiatry 2005; 14: 341-350.
63. Kydd RR, Werry JS. Schizophrenia in children under 16 years. J Autism Dev Disord 1982; 12: 343-357.
64. Fleischhaker C, Schulz E, Tepper K, Martin M, Hennighausen K, Remschmidt H. Long-Term course of adolescent schizophrenia. Schizophr Bull 2005; 31: 769-780.
65. Strous RD, Alvir JM, Robinson D, Gal G, Sheitman B, Chakos M et al. Premorbid functioning in schizophrenia: relation to baseline symptoms, treatment response, and medication side effects. Schizophr Bull 2004; 30: 265-278.
66. Jeppesen P, Petersen L, Thorup A, Abel MB, Ohlenschlaeger J, Christensen TO et al. The association between pre-morbid adjustment, duration of untreated psychosis and outcome in first-episode psychosis. Psychol Med 2008; 38: 1157-1166.
67. Verdoux H, Liraud F, Bergey C, Assens F, Abalan F, van Os J. Is the association between duration of untreated psychosis and outcome confounded? A two year follow-up study of first-Admitted patients. Schizophr Res 2001; 49: 231-241.
68. Dominguez MD, Fisher HL, Major B, Chisholm B, Rahaman N, Joyce J et al. Duration of untreated psychosis in adolescents: ethnic differences and clinical profiles. Schizophr Res 2013; 150: 526-532.
69. McCrone P, Singh SP, Knapp M, Smith J, Clark M, Shiers D et al. The economic impact of early intervention in psychosis services for children and adolescents. Early Interv Psychiatry 2013; 7: 368-373.
70. Hafner H. Gender differences in schizophrenia. Psychoneuroendocrinology 2003; 28(Suppl 2): 17-54.
71. Hafner H, Maurer K, Loffler W, Riecher-Rossler A. The influence of age and sex on the onset and early course of schizophrenia. Br J Psychiatry 1993; 162: 80-86.
72. Eggers C, Bunk D. The long-Term course of childhood-onset schizophrenia: a 42-year followup. Schizophr Bull 1997; 23: 105-117.
73. Werry JS, McClellan JM, Chard L. Childhood and adolescent schizophrenic, bipolar, and schizoaffective disorders: a clinical and outcome study. J Am Acad Child Adolesc Psychiatry 1991; 30: 457-465.
74. Milev P, Ho BC, Arndt S, Andreasen NC. Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal firstepisode study with 7-year follow-up. Am J Psychiatry 2005; 162: 495-506.
75. Puig O, Penades R, Baeza I, De La Serna E, Sanchez-Gistau V, Bernardo M et al. Cognitive remediation therapy in adolescents with early-onset schizophrenia: a randomized controlled trial. J Am Acad Child Adolesc Psychiatry 2014; 53: 859-868.
76. Singh I, Rose N. Biomarkers in psychiatry. Nature 2009; 460: 202-207.
77. Fraguas D, Gonzalez-Pinto A, Mico JA, Reig S, Parellada M, Martinez-Cengotitabengoa M et al. Decreased glutathione levels predict loss of brain volume in children and adolescents with first-episode psychosis in a twoyear longitudinal study. Schizophr Res 2012; 137: 58-65.
78. Martinez-Cengotitabengoa M, Mico JA, Arango C, Castro-Fornieles J, Graell M, Paya B et al. Basal low antioxidant capacity correlates with cognitive deficits in early onset psychosis. A 2-year follow-up study. Schizophr Res 2014; 156: 23-29.
79. Mico JA, Rojas-Corrales MO, Gibert-Rahola J, Parellada M, Moreno D, Fraguas D et al. Reduced antioxidant defense in early onset first-episode psychosis: a casecontrol study. BMC Psychiatry 2011; 11: 26.
80. Cabungcal JH, Counotte DS, Lewis EM, Tejeda HA, Piantadosi P, Pollock C et al. Juvenile antioxidant treatment prevents adult deficits in a developmental model of schizophrenia. Neuron 2014; 83: 1073-1084.
81. Greenstein DK, Wolfe S, Gochman P, Rapoport JL, Gogtay N. Remission status and cortical thickness in childhood-onset schizophrenia. J Am Acad Child Adolesc Psychiatry 2008; 47: 1133-1140.
82. Parellada M, Boada L, Fraguas D, Reig S, Castro-Fornieles J, Moreno D et al. Trait and state attributes of insight in first episodes of early-onset schizophrenia and other psychoses: a 2-year longitudinal study. Schizophr Bull 2011; 37: 38-51.
83. Castro-Fornieles J. Child and adolescent psychiatry: the need for training and development. Rev Psiquiatr Salud Ment 2013; 6: 57-59.
84. Ledda MG, Fratta AL, Pintor M, Zuddas A, Cianchetti C. Early-onset psychoses: comparison of clinical features and adult outcome in 3 diagnostic groups. Child Psychiatry Hum Dev 2009; 40: 421-437.
85. Janssen J, Reig S, Parellada M, Moreno D, Graell M, Fraguas D et al. Regional gray matter volume deficits in adolescents with first-episode psychosis. J Am Acad Child Adolesc Psychiatry 2008; 47: 1311-1320.
86. Maziade M, Bouchard S, Gingras N, Charron L, Cardinal A, Roy MA et al. Longterm stability of diagnosis and symptom dimensions in a systematic sample of patients with onset of schizophrenia in childhood and early adolescence. II: Postnegative distinction and childhood predictors of adult outcome. Br J Psychiatry 1996; 169: 371-378.
87. Jarbin H, Hansson L. Adult quality of life and associated factors in adolescent onset schizophrenia and affective psychotic disorders. Soc Psychiatry Psychiatr Epidemiol 2004; 39: 725-729.
88. Bunk D, Eggers C, Volberg G, Schebaum-Stein T. Dimensions of premorbid disorders in childhood-onset schizophrenia (COS). Neurol Psychiatry Brain Res 2003; 10: 183-192.
89. Baeza I, Graell M, Moreno D, Castro-Fornieles J, Parellada M, Gonzalez-Pinto A et al. Cannabis use in children and adolescents with first episode psychosis: influence on psychopathology and short-Term outcome (CAFEPS study). Schizophr Res 2009; 113: 129-137.
90. Wozniak JR, Block EE, White T, Jensen JB, Schulz SC. Clinical and neurocognitive course in early-onset psychosis: a longitudinal study of adolescents with schizophrenia-spectrum disorders. Early Interv Psychiatry 2008; 2: 169-177.
91. Mayoral M, Zabala A, Robles O, Bombin I, Andres P, Parellada M et al. Neuropsychological functioning in adolescents with first episode psychosis: a twoyear follow-up study. Eur Psychiatry 2008; 23: 375-383.
92. Cawthron P, James A, Dell J, Seagroatt V. Adolescent onset psychosis. A clinical and outcome study. J Child Psychol Psychiatry 1994; 35: 1321-1332.
93. Eggers C, Bunk D, Volberg G, Ropcke B. The ESSEN study of childhood-onset schizophrenia: selected results. Eur Child Adolesc Psychiatry 1999; 8(Suppl 1): I21-I28.
94. Schimmelmann BG, Conus P, Cotton S, Kupferschmid S, McGorry PD, Lambert M. Prevalence and impact of cannabis use disorders in adolescents with early onset first episode psychosis. Eur Psychiatry 2012; 27: 463-469.
95. Amminger GP, Resch F, Mutschlechner R, Friedrich MH, Ernst E. Premorbid adjustment and remission of positive symptoms in first-episode psychosis. Eur Child Adolesc Psychiatry 1997; 6: 212-218.
96. Gearing RE, Mian I, Sholonsky A, Barber J, Nicholas D, Lewis R et al. Developing a risk-model of time to first-relapse for children and adolescents with a psychotic disorder. J Nerv Ment Dis 2009; 197: 6-14.
97. Jarbin H, Grawe RW, Hansson K. Expressed emotion and prediction of relapse in adolescents with psychotic disorders. Nord J Psychiatry 2000; 54: 201-205.
98. Gearing RE, Charach A. Medication adherence for children and adolescents with first-episode psychosis following hospitalization. Eur Child Adolesc Psychiatry 2009; 18: 587-595.
99. Noguera A, Ballesta P, Baeza I, Arango C, de la Serna E, Gonzalez-Pinto A et al. Twenty-four months of antipsychotic treatment in children and adolescents with first psychotic episode: discontinuation and tolerability. J Clin Psychopharmacol 2013; 33: 463-471.
100. Parellada M, Fraguas D, Bombin I, Otero S, Castro-Fornieles J, Baeza I et al. Insight correlates in child-And adolescent-onset first episodes of psychosis: results from the CAFEPS study. Psychol Med 2009; 39: 1433-1445.
101. Sanchez-Gistau V, Baeza I, Arango C, Gonzalez-Pinto A, de la Serna E, Parellada M et al. Predictors of suicide attempt in early-onset, first-episode psychoses: a longitudinal 24-month follow-up study. J Clin Psychiatry 2013; 74: 59-66.
102. Jarbin H, Von Knorring AL. Suicide and suicide attempts in adolescent-onset psychotic disorders. Nord J Psychiatry 2004; 58: 115-123.
103. Jarbin H, Ott Y, Von Knorring AL. Adult outcome of social function in adolescentonset schizophrenia and affective psychosis. J Am Acad Child Adolesc Psychiatry 2003; 42: 176-183.
104. Werry JS, McClellan JM, Andrews LK, Ham M. Clinical features and outcome of child and adolescent schizophrenia. Schizophr Bull 1994; 20: 619-630.
105. Sporn AL, Vermani A, Greenstein DK, Bobb AJ, Spencer EP, Clasen LS et al. Clozapine treatment of childhood-onset schizophrenia: evaluation of effectiveness, adverse effects, and long-Term outcome. J Am Acad Child Adolesc Psychiatry 2007; 46: 1349-1356.
106. McClellan J, McCurry C, Speltz ML, Jones K. Symptom factors in early-onset psychotic disorders. J Am Acad Child Adolesc Psychiatry 2002; 41: 791-798.
107. Remschmidt H, Martin M, Fleischhaker C, Theisen FM, Hennighausen K, Gutenbrunner C et al. Forty-Two-years later: the outcome of childhood-onset schizophrenia. J Neural Transm 2007; 114: 505-512.
108. Vyas NS, Hadjulis M, Vourdas A, Byrne P, Frangou S. The Maudsley early onset schizophrenia study. Predictors of psychosocial outcome at 4-year follow-up. Eur Child Adolesc Psychiatry 2007; 16: 465-470.
109. Oie M, Sundet K, Ueland T. Neurocognition and functional outcome in earlyonset schizophrenia and attention-deficit/hyperactivity disorder: a 13-year follow-up. Neuropsychology 2011; 25: 25-35.
110. Cervellione KL, Burdick KE, Cottone JG, Rhinewine JP, Kumra S. Neurocognitive deficits in adolescents with schizophrenia: longitudinal stability and predictive utility for short-Term functional outcome. J Am Acad Child Adolesc Psychiatry 2007; 46: 867-878.
111. Schmidt M, Blanz B, Dippe A, Koppe T, Lay B. Course of patients diagnosed as having schizophrenia during first episode occurring under age 18 years. Eur Arch Psychiatry Clin Neurosci 1995; 245: 93-100.
112. de la Serna E, Andres-Perpina S, Puig O, Baeza I, Bombin I, Bartres-Faz D et al. Cognitive reserve as a predictor of two year neuropsychological performance in early onset first-episode schizophrenia. Schizophr Res 2013; 143: 125-131.
113. Thompson PM, Vidal C, Giedd JN, Gochman P, Blumenthal J, Nicolson R et al. Mapping adolescent brain change reveals dynamic wave of accelerated gray matter loss in very early-onset schizophrenia. Proc Natl Acad Sci USA 2001; 98: 11650-11655.
114. Arango C, Rapado-Castro M, Reig S, Castro-Fornieles J, Gonzalez-Pinto A, Otero S et al. Progressive brain changes in children and adolescents with first-episode psychosis. Arch Gen Psychiatry 2012; 69: 16-26.
115. Sporn AL, Greenstein DK, Gogtay N, Jeffries NO, Lenane M, Gochman P et al. Progressive brain volume loss during adolescence in childhood-onset schizophrenia. Am J Psychiatry 2003; 160: 2181-2189.
116. Rapoport JL, Giedd JN, Blumenthal J, Hamburger S, Jeffries N, Fernandez T et al. Progressive cortical change during adolescence in childhood-onset schizophrenia. A longitudinal magnetic resonance imaging study. Arch Gen Psychiatry 1999; 56: 649-654.
117. Gogtay N, Sporn A, Clasen LS, Nugent TF 3rd, Greenstein D, Nicolson R et al. Comparison of progressive cortical gray matter loss in childhood-onset schizophrenia with that in childhood-onset atypical psychoses. Arch Gen Psychiatry 2004; 61: 17-22.
118. Jacobsen LK, Giedd JN, Castellanos FX, Vaituzis AC, Hamburger SD, Kumra S et al. Progressive reduction of temporal lobe structures in childhood-onset schizophrenia. Am J Psychiatry 1998; 155: 678-685.